TY - JOUR
T1 - Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty
AU - Schwarzacher, Severin P.
AU - Lim, Tai T.
AU - Wang, Bingyin
AU - Kernoff, Robert S.
AU - Niebauer, Josef
AU - Cooke, John P.
AU - Yeung, Alan C.
PY - 1997/4/1
Y1 - 1997/4/1
N2 - Background: Long-term oral administration of L-arginine has been shown to enhance production of nitric oxide (NO) and to reduce lesion formation. The goal of this study was to determine whether local intramural administration of L-arginine could enhance NO generation and reduce intimal thickening. Methods and Results: New Zealand while rabbits (n=27) received a 1% cholesterol diet. For the short-term study, after 1 week of diet, both iliac arteries were balloon injured. Four weeks later, vasoreactivity was assessed angiographically during infusion of acetylcholine (Ach) before and after delivery of L-arginine or saline into the right or left iliac artery (800 mg/5 mL; 0,2 mL/min, 15 minutes) by use of a local drug-delivery balloon. Vessels were then harvested for measurements of NO. For the long- term study, after balloon injury, drugs were delivered as above into the iliac arteries. Two and 4 weeks after L-arginine delivery, vasoreactivity was determined. Subsequently, the iliac arteries were harvested for histomorphometric analysis and measurements of NO. In the short-term study, local delivery of L-arginine restored endothelium-dependent vasodilatation (Ach 10 5 mol/L; L-arginine +35±10%; saline 14±5%; P<.001) and enhanced local production of nitrogen oxides (L-arginine 152±28; saline 78± 12 nmol/L per milligram of tissue per hour; P<.04). In the long-term study, local administration of L-arginine enhanced vascular NO production as long as 1 week after the injury (L-arginine 394.4±141.6; saline 86.3±34.3 nmol/L per milligram of tissue per hour; P<.01) and reduced intimal thickening 4 weeks later (intima/media ratio: L-arginine 0.56±0.1; saline 1.40±0.2; P<.001), largely due to suppression of macrophage accumulation. Conclusions: A single intramural administration of L-arginine enhances vascular NO generation and inhibits lesion formation. Local augmentation of NO production at the site of balloon angioplasty may be a novel strategy to prevent restenosis.
AB - Background: Long-term oral administration of L-arginine has been shown to enhance production of nitric oxide (NO) and to reduce lesion formation. The goal of this study was to determine whether local intramural administration of L-arginine could enhance NO generation and reduce intimal thickening. Methods and Results: New Zealand while rabbits (n=27) received a 1% cholesterol diet. For the short-term study, after 1 week of diet, both iliac arteries were balloon injured. Four weeks later, vasoreactivity was assessed angiographically during infusion of acetylcholine (Ach) before and after delivery of L-arginine or saline into the right or left iliac artery (800 mg/5 mL; 0,2 mL/min, 15 minutes) by use of a local drug-delivery balloon. Vessels were then harvested for measurements of NO. For the long- term study, after balloon injury, drugs were delivered as above into the iliac arteries. Two and 4 weeks after L-arginine delivery, vasoreactivity was determined. Subsequently, the iliac arteries were harvested for histomorphometric analysis and measurements of NO. In the short-term study, local delivery of L-arginine restored endothelium-dependent vasodilatation (Ach 10 5 mol/L; L-arginine +35±10%; saline 14±5%; P<.001) and enhanced local production of nitrogen oxides (L-arginine 152±28; saline 78± 12 nmol/L per milligram of tissue per hour; P<.04). In the long-term study, local administration of L-arginine enhanced vascular NO production as long as 1 week after the injury (L-arginine 394.4±141.6; saline 86.3±34.3 nmol/L per milligram of tissue per hour; P<.01) and reduced intimal thickening 4 weeks later (intima/media ratio: L-arginine 0.56±0.1; saline 1.40±0.2; P<.001), largely due to suppression of macrophage accumulation. Conclusions: A single intramural administration of L-arginine enhances vascular NO generation and inhibits lesion formation. Local augmentation of NO production at the site of balloon angioplasty may be a novel strategy to prevent restenosis.
KW - endothelium-derived factors
KW - L-arginine
KW - macrophages
KW - restenosis
UR - http://www.scopus.com/inward/record.url?scp=0030999244&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030999244&partnerID=8YFLogxK
U2 - 10.1161/01.CIR.95.7.1863
DO - 10.1161/01.CIR.95.7.1863
M3 - Article
C2 - 9107174
AN - SCOPUS:0030999244
SN - 0009-7322
VL - 95
SP - 1863
EP - 1869
JO - Circulation
JF - Circulation
IS - 7
ER -